Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Singapore Retail IDP Refresh Pushes AI Tools for Staff Training and Revenue Growth IREN Stock Surges After 16 Billion Dell Deal to Accelerate AI Infrastructure Buildout Alibaba Advances AI Ambitions with Enhanced Zhenwu Chip and New Large Language Model Ferraris First EV Launch Sends Shares Lower as Market Reacts AI Rally Powers SK Hynix and Micron Into 1 Trillion Market Cap Club CGBD Q1 2026 Earnings Narrow EPS Miss Amid Stable Credit Performance Personalis Q1 2026 Earnings EPS Misses Estimates as Stock Gains Amid Sparse Financial Disclosure ASST Q1 2026 Earnings EPS Misses Estimates by Wide Margin Stock Declines SENEA Q1 2026 Earnings Strong EPS of 619 Reported Amid Quiet Market Reaction Smith Nephew SNN Q4 2014 Earnings Narrow EPS Beat Fails to Lift Shares Republic Digital Acquisition Corp Unit RDAGU Holds Steady at 1055 as SPAC Unit Trades Flat Actinium Pharmaceuticals ATNM Modest Gain Above Support as Biotech Stock Holds Key Level Oculis Holding OCS Slips 1 as Stock Consolidates Near Support Levels Takeda Pharmaceutical TAK Faces Resistance at 1673 Slips 2 Amid Sector Weakness Sensex Surges 800 Points Nifty Climbs Above 23950 Auto and Banking Stocks Lead Rally Fed Rate Cut Prospects Dim as April Jobs Report Signals Labor Market Stability Analysts Point to Potential Upside for Ondas Inc ONDS Gates Foundation Exits Microsoft as Ackman Builds Stake Divergent Views on Tech Giants Future ATPC Q4 2024 Earnings Net Loss of 020 Per Share Stock Rises Sharply Reliance Inc RS Q1 2026 Earnings Strong EPS Beat Drives Stock Higher ESAB Q1 2026 Earnings EPS Slightly Misses Expectations Amid Steady Execution Backblaze BLZE Q1 2026 Earnings EPS Misses Estimates but Stock Gains 4 on Operational Momentum PAGP Q1 2026 Earnings Massive EPS Surprise Highlights Resilient Midstream Operations Unicycive Therapeutics UNCY Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Continues Development